| Expression pattern: |
UP |
| Associated gene: |
SKA1, MRP1, MDR1, LRP1, Notch2, GSK-3beta, beta-catenin |
| Associated microRNA: |
miR-525-5p |
| Biological function: |
Promotes oxaliplatin resistance (increases IC50) and enhances migration and invasion while inhibiting apoptosis in OX-resistant breast cancer cells. |
| Molecular mechanism: |
circFAT1 sponges miR-525-5p to upregulate SKA1, which activates Notch and Wnt signaling pathways to drive oxaliplatin resistance. |
| Biological pathway or process: |
Notch (promotes); Wnt/beta-catenin (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); chemoresistance (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Luciferase Reporter Assay; Transfection; CCK8; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
Higher circFAT1 expression is associated with oxaliplatin-resistant breast cancer tissues, suggesting a potential therapeutic target in OX-resistant BC. |
| Description: |
circFAT1 is upregulated in oxaliplatin-resistant breast cancer tissues/cells and promotes oxaliplatin resistance, migration, and invasion while suppressing apoptosis. Mechanistically, it targets (sponges) miR-525-5p to increase SKA1, which in turn activates Notch and Wnt signaling. |
| Confidence score: |
0.5607 |